Vaxart terminates headquarters lease early; relocation to other South SF office

Vaxart, Inc.

Lease termination effective May 15, 2026, ~3 years early (original expiry March 31, 2029).
Premises: 24,606 sq ft at 170 Harbor Way, South San Francisco.
No termination fees or penalties payable to landlord.
Company to relocate headquarters and labs to another existing office in South SF area.
Termination part of ongoing cost reduction initiatives.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 1.0

Vaxart, Inc. terminated Lease Agreement with Britannia Pointe Grand Limited Partnership valued at Termination of Lease Agreement effective May 15, 2026 (effective 2025-12-18).

Action: termination
Agreement: lease
Counterparty: Britannia Pointe Grand Limited Partnership
Value: Termination of Lease Agreement effective May 15, 2026
Effective: 2025-12-18

Exact text from the filing

On December 18, 2025, Vaxart, Inc., a Delaware corporation (the “Company”), entered into a termination agreement (the “Termination Agreement”) with Britannia Pointe Grand Limited Partnership, a Delaware limited partnership (the “Landlord”), in connection with the termination of that certain lease agreement, by and between the Landlord and the Company, dated September 17, 2021 (the “Lease”) for certain premises located at 170 Harbor Way, South San Francisco, California 94080 that served as the Company’s headquarters.

View on SEC.gov

290 material agreements filed in the last 30 days. Browse all material agreements →

Vaxart, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-038774

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.